Table 2.

Differences in outcomes between women and men.

	All			Placebo arm			Spironolactone arm
	Women	Man	p	Women	Men	P	Women	Men	p
	(n = 898)	(n = 721)		(n = 445)	(n = 363)		(n = 453)	(n = 358)
Primary outcome, n (%)	165 (18.4)	198 (27.5)	<0.001	84 (18.9)	102 (28.1)	0.002	81 (17.9)	96 (26.8)	0.002
CV mortality, n (%)	80 (8.9)	107 (14.8)	<0.001	47 (10.6)	56 (15.4)	0.039	33 (7.3)	51 (14.2)	0.001
HF hospitalization, n (%)	120 (13.4)	131 (18.2)	0.008	60 (13.5)	69 (19.0)	0.033	60 (13.2)	62 (17.3)	0.107
All-cause mortality, n (%)	140 (15.6)	183 (25.4)	<0.001	140 (31.5)	183 (50.4)	<0.001	59 (13.0)	92 (25.7)	<0.001
All-cause hospitalization, n (%)	422 (47.0)	384 (52.3)	0.012	216 (48.5)	193 (53.2)	0.191	206 (45.5)	191 (53.4)	0.026

Values are n (%). Chi-square tests for women vs. men. Abbreviations as in Table 1.